Inherited Mutations in Women With Ovarian Carcinoma - Test2 - elhamkhani - TriplyDB

Inherited Mutations in Women With Ovarian Carcinoma

Inherited Mutations in Women With Ovarian Carcinoma

http://www.wikidata.org/entity/Q30353433

about

Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Confronting the Care Delivery Challenges Arising from Precision Medicine PALB2: research reaching to clinical outcomes for women with breast cancer Malignant Brenner tumor associated with a germline BRCA2 mutation.Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.Counselling framework for moderate-penetrance cancer-susceptibility mutations.Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence Genetic characterization of early onset ovarian carcinoma.Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells.When Genome Maintenance Goes Badly Awry.Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient.New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes Pathogenesis and heterogeneity of ovarian cancer.Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.BRCA mutation in ovarian cancer: testing, implications and treatment considerations.A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.Risk-reducing salpingectomy: Let us be opportunistic.Therapeutic targeting and patient selection for cancers with homologous recombination defects.Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening.The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.Frequency of germline PALB2 mutations among women with epithelial ovarian cancer.Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.Ovarian Cancer Prevention in High-risk Women.Somatic TP53 variants frequently confound germ-line testing results.Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: an NRG Oncology/Gynecologic Oncology Group Study.Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.Dualistic Role of BARD1 in Cancer.Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.

P2860

Q26740622-9120CF20-53B2-4B91-80C8-A919F8A1F2DE Q26747279-3104D61C-4D4B-4411-835E-F9D58169D6DB Q26747282-4856D6EF-10BB-42C0-8E62-C5D991EDCD8B Q26751309-EF7CC77C-05CA-49C0-83C3-64BA837EBEF1 Q33763270-9BE1474E-7CD5-4765-965F-CDD463D771AA Q33772896-09B6AAD8-DBE5-49E9-9EEB-87299398C39D Q33911135-ACE5F4C6-64F0-4343-882C-C82B0ABF7CEB Q36077722-A1AB3343-3BF1-4F75-BF2D-49211AD58764 Q36908973-8B917657-4BFE-4A93-A7B3-472ACE1C1A41 Q37137451-E4460C4C-6207-4571-8F0A-937937C4F322 Q37138583-F16D89D8-3BBB-4239-A9E6-CC2418C238C1 Q37171584-FC85A8D6-4647-4CC9-873E-57C747EC086B Q37398841-D120A8FE-D271-4C89-A7C6-E9D29F7F2F09 Q37519943-FD98B3B9-F7C1-4C12-8458-C2B2988CBFB0 Q37546692-9BE85922-A6D7-45AA-B042-D2F61E113D84 Q37590600-62039D6D-674F-4F95-961F-A0197908F66C Q37620476-3133FBDD-47B0-43C9-9C1F-639BF3E841AF Q37709179-722362C9-7A92-41F5-9BA4-D40216DFFC00 Q38618465-3D97A47E-2B2A-411A-B878-4E5BD8A7FBD1 Q38644661-BAD798C9-597C-49D3-BBBB-194113ABFB96 Q38850529-29A156C3-A482-4086-8250-8A512DE4A2B9 Q38905495-2015A33B-CAFC-4985-8BB3-1F529190728B Q39196159-98EC2545-E54E-4261-A740-B3A56D94EB63 Q39251572-EFDB6324-676E-4EBE-A624-5C9F578C6D5B Q39309080-0A8AF4D7-A37A-4732-9572-BFC0B3AFF125 Q39421659-4B55283E-5193-4B9F-B0B8-A35D517E0FD3 Q40063188-E748DDD6-75B3-419B-A9BB-E3D58C79C5B0 Q40580115-2597EE56-E4C8-41A4-9E96-A33EB8A36C04 Q41691425-71FD042D-4B2F-4A48-B88C-48A1417EDD7F Q42379886-17332BCA-1A37-4D0B-B38E-FFF8697B1339 Q42683589-93347744-2F16-4002-8228-170820991733 Q43821846-C27D0949-133E-4A4A-8ABC-52C3589A2E4A Q45068704-A53B02B8-159E-4FD4-AD6D-A070E106D32B Q46051827-B463A2F9-0E60-4D06-9254-38B0F5DE3B49 Q46567658-63B05E7C-4A57-4308-B404-8663C3C04D02 Q46727853-4D0AC66D-ECF0-4B58-A31C-4DAE06A52278 Q46782579-F444804E-DF0A-48B6-A547-7AD88B513334 Q47177315-6D718145-4101-48FE-9FA6-4280E9DF7337 Q47397232-2B36F794-53A8-4C91-A6FF-EBC4E286C862 Q47549253-FEACB54E-7AC6-45C3-8C0A-0EBFC02C26DF

P2860

Inherited Mutations in Women With Ovarian Carcinoma

http://www.wikidata.org/entity/Q30353433

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Inherited Mutations in Women With Ovarian Carcinoma

@ast

Inherited Mutations in Women With Ovarian Carcinoma

@en

type

label

Inherited Mutations in Women With Ovarian Carcinoma

@ast

Inherited Mutations in Women With Ovarian Carcinoma

@en

prefLabel

Inherited Mutations in Women With Ovarian Carcinoma

@ast

Inherited Mutations in Women With Ovarian Carcinoma

@en

P1433

Q30353433-2E69E456-DEB3-41EF-A3FC-F8037E14A733

P1476

Q30353433-A7C0D163-FED3-43D3-8963-0A996816C6AD

P2093

Q30353433-0A335EF6-DA9D-4F16-A267-F979806C2A95

Q30353433-1099B99B-341B-4580-A2AB-B0D5651926AD

Q30353433-14A20604-786B-45CD-B280-6E9F49F9792B

Q30353433-309872EF-C649-4F6B-BCDB-7E0A7E251463

Q30353433-4AD449FC-DC38-4236-9592-F69EBB79041E

Q30353433-50AAE785-80CB-4302-BBDF-9A070D34D44A

Q30353433-691BB686-34FE-4D6F-8043-809512ACE46F

Q30353433-750CFEE9-595C-4FE2-8D26-26320B0599C6

Q30353433-9EA9F4B5-3F2D-4219-8DFE-466020F438FD

Q30353433-A4672230-5EBB-4A76-A389-DA604957C05F

P2860

Q30353433-099CE6A0-5076-4921-894C-03163DB200F9

Q30353433-1FF878C6-2B5D-4F10-A9CA-EBC08434E793

Q30353433-22711448-D0BE-48FA-99F5-14AAAF6D034B

Q30353433-22EE4DAC-A03E-407E-8790-08B6023F1AFA

Q30353433-277680BC-ED51-43C9-8D7D-E65D60DCE522

Q30353433-3F68571F-457D-47AB-88FB-1823D91DD1A0

Q30353433-42F6F926-29B7-4035-981C-17F7BC4042DF

Q30353433-49DDE85B-EBC1-4FBD-B1E9-85D9C078FF84

Q30353433-4D0142C7-1790-4F38-A1E3-2EE37EA206C6

Q30353433-53F41AD3-6737-43A2-B1A0-DBEFBB242742

P304

Q30353433-8183D257-09B9-4017-B103-561CC7179CE4

P31

Q30353433-6E6E8506-4FF8-482A-B913-2877FD99C5A4

P356

Q30353433-194FCF41-5202-4AEF-A1EF-2EF59D10F981

P433

Q30353433-E83305FB-5C7A-401D-8821-E126D1E37BFF

P478

Q30353433-79A08D96-F14D-4209-B02B-E1FDB9302ECA

P50

Q30353433-5230C7EE-6FF4-481D-B827-8EED18AC1E0A

Q30353433-941C556B-D662-4E9B-A0B3-4EC559235C8A

Q30353433-B6B0A9F9-2BDD-4095-AA34-8E393766A170

P577

Q30353433-2C7D7D80-0D47-49FC-9B00-F01DFC0DD828

P698

Q30353433-2DDFCE69-849B-4656-8F1A-9931C8E11EB2

P932

Q30353433-C3B951AF-EE7D-401C-B672-36CC3AD35909

P356

JAMAONCOL.2015.5495

P1433

P1476

Inherited Mutations in Women With Ovarian Carcinoma

@en

P2093

Elizabeth M Swisher

http://www.w3.org/2001/XMLSchema#string

Heather A Lankes

http://www.w3.org/2001/XMLSchema#string

John K Chan

http://www.w3.org/2001/XMLSchema#string

Maria I Harrell

http://www.w3.org/2001/XMLSchema#string

Mark F Brady

http://www.w3.org/2001/XMLSchema#string

Michael J Birrer

http://www.w3.org/2001/XMLSchema#string

Ming K Lee

http://www.w3.org/2001/XMLSchema#string

Nilsa C Ramirez

http://www.w3.org/2001/XMLSchema#string

Paul A DiSilvestro

http://www.w3.org/2001/XMLSchema#string

Qian Yi

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

Structure of a BRCA1-BARD1 heterodimeric RING-RING complex

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

Cancer statistics, 2015

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

PALB2: the hub of a network of tumor suppressors involved in DNA damage responses

Germline mutations in RAD51D confer susceptibility to ovarian cancer

P304

482-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAONCOL.2015.5495

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Norquist

Mary-Claire King

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26720728

http://www.w3.org/2001/XMLSchema#string

P932

4845939

http://www.w3.org/2001/XMLSchema#string